Casey Eye Institute, Oregon Health & Sciences University, Portland, Oregon, United States.
Retina Foundation of the Southwest, Dallas, Texas, United States.
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5941-5956. doi: 10.1167/iovs.18-24565.
Prospective evaluation of patients with X-linked retinoschisis (XLRS).
Fifty-six males XLRS patients, age ≥7 years, had retinal structure and function tests performed every 6 months during an 18-month period.
Best corrected visual acuity (BCVA) was abnormal (mean ± SD logMAR 0.57 ± 0.32 OD and 0.50 ± 0.27 OS), with weak correlation between visual acuity and age (R = -0.24, P = 0.0095). Mean cyst cavity volume (CCV) determined on optical coherence tomography showed weak correlation with age (R = -0.33, P = 0.0009) and no correlation with visual acuity. Subjects had modest reduction in mean kinetic and static perimetry results, reduced b-wave amplitude on electroretinography, abnormal reading speed results, and decreased visual function quality of life scores. Contrast sensitivity results were normal in 85 of 99 eyes tested. Most subjects had no meaningful change in BCVA during follow-up. Subjects who started carbonic anhydrase inhibitor (CAI) treatment at enrollment had improved BCVA (mean ± SD change 3.15 ± 7.8 ETDRS letters, with increase of ≥15 ETDRS letters at 8 of 110 visits [in 3 subjects]). There were no significant changes in other parameters tested.
Structural and functional results were stable during the 18-month follow-up period. Some patients starting CAI treatment at the baseline visit showed improvement in BCVA that was not correlated with changes in CCV. Natural history data such as these will be important for comparisons to the changes in measures of retinal structure and function following gene replacement therapy in patients with XLRS.
对 X 连锁性视网膜劈裂症(XLRS)患者进行前瞻性评估。
56 名年龄≥7 岁的男性 XLRS 患者在 18 个月期间每 6 个月进行一次视网膜结构和功能检查。
最佳矫正视力(BCVA)异常(均值±标准差 logMAR 0.57±0.32 OD 和 0.50±0.27 OS),视力与年龄之间相关性较弱(R=-0.24,P=0.0095)。光学相干断层扫描(OCT)确定的平均囊腔容积(CCV)与年龄呈弱相关(R=-0.33,P=0.0009),与视力无关。患者的平均运动和静态视野检查结果均有所下降,视网膜电图的 b 波振幅降低,阅读速度检查结果异常,视觉功能生活质量评分降低。99 只受检眼中有 85 只的对比敏感度结果正常。大多数患者在随访期间 BCVA 无明显变化。在入组时开始使用碳酸酐酶抑制剂(CAI)治疗的患者 BCVA 得到改善(平均±标准差变化 3.15±7.8 ETDRS 字母,110 次就诊中有 8 次[3 例患者]增加≥15 ETDRS 字母)。其他测试参数无明显变化。
在 18 个月的随访期间,结构和功能结果保持稳定。一些在基线就诊时开始使用 CAI 治疗的患者,BCVA 得到改善,与 CCV 的变化无关。这些自然史数据对于比较 XLRS 患者接受基因替代治疗后视网膜结构和功能测量的变化将非常重要。